The effect of cyclosporin A administration on bone metabolism in the rat evaluated by biochemical markers

Journal of Endocrinological Investigation

Volumn 19, Issue 8, 1996, Pages 499-504

  Kawana, K ^a   Takahashi, M ^a   Kushida, K ^a   Hoshino, H ^a   Sakata, S ^a   Inoue, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone histomorphometry; Deoxypyridinoline; Osteocalcin; Pyridinoline; Uncoupling

Indexed keywords

BIOCHEMICAL MARKER; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE METABOLISM; BONE REMODELING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MORPHOMETRICS; NONHUMAN; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOID; OSTEOLYSIS; RAT; TRABECULAR BONE;

EID: 10344266434     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03349007     Document Type: Article

References (31)

1. Katz I.A., Epstein S. Posttransplantation bone disease. J. Bone Miner. Res. 7: 123, 1992.
2. Zeevi A., Eiras G., Bach F.H., Fung J.J., Todo S., Starzl T., Duquesnoy R.J. Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CsA. Transplant. Proc. 22: 106, 1990.
3. McKenna R.M., Szturm K., Jeffery J.R., Rush D.N. Inhibition of cytokine production by cyclosporin A and G. Transplantation 47: 343, 1989.
4. Kay J.E., Moore A.L., Doe S.E.A., Benzie C.R., Schonbrunner R., Schmid F.X., Halestrap A.P. The mechanism of action of FK 506. Transplant. Proc. 22: 96, 1990.
5. Canalis E., McCarthy T., Centrella M. Growth factors and the regulation of bone remodeling. J. Clin. Invest. 81: 277, 1988.
6. Stein B., Takizawa M., Katz I., Joffe I., Berlin J., Fallon M., Epstein S. Salmon calcitonin prevents cyclosporin-A- induced high turnover bone loss. Endocrinology 129: 92, 1991.
7. Orcel P., Bielakoff J., Modrowski D., Miravet L., Vernejoul M.C. Cyclosporin A induces in vivo inhibition of resorption and stimulation of formation in rat bone. J. Bone Miner. Res. 3: 387, 1989.
8. Eyre D.R. Collagen cross-linking amino acids. Methods Enzymol 144: 115, 1987.
9. Robins S.P., Black D., Paterson C.R., Reid M., Duncan A., Seibei M.J. Evaluation of urinary hydroxypyridinum crosslink measurements as resorption markers in metabolic bone diseases. Eur. J. Clin. Invest. 21: 310, 1991.
10. Ohishi T., Takahashi M., Kushida K., Horiuchi K., Ishigaki S., Inoue T. Quantitative analysis of urinary pyridinoline and deoxypyridinoline excretion in patients with hyperthyroidism. Endocr. Res. 18: 281, 1992.
11. Black D., Farquharson C., Robins S.P. Excretion of pyridinum cross-links of collagen in ovariectomized rats as urinary markers for increased bone resorption. Calcif. Tissue Int. 44: 343, 1989.
12. Jerome C.P., Colwell A., Eastell R., Russell R.G.G., Trechsel U. The effect of rat parathyroid hormone (1-34) infusion on urinary 3-hydroxypyridium cross-link excretion in the rat. Bone and Mineral 19: 117, 1992.
13. Nishimoto S.K., Price P.A. Secretion of the vitamine K-dependent protein of bone by rat osteosarcoma cells. J. Biol. Chem. 255: 6579, 1980.
14. Price P.A., Parthemore J.G., Deftos L.J. New biochemical marker for bone metabolism. J. Clin. Invest. 66: 878, 1980.
15. Brown J.P., Delmas P.D., Malaval L., Edouard C., Chapuy M.C., Meunier P.J. Serum bone gla protein, a specific marker for bone formation in postmenopausal osteoporosis. Lancet 19: 1091, 1984.
16. Ohta T., Azuma Y., Kiyoki M., Eguchi H., Arita M., Hosoda K., Tsukamoto Y., Nakamura T. Measurement of intact rat osteocalcin in osteoblast (ROS17/2.8) cells and in ovariectomized rats with a sandwich enzyme immunoassay. Calcif. Tissue Int. (in press).
17. Takahashi M., Ohishi T., Aoshima H., Kushida K., Inoue T., Horiuchi K. Pre-fractionation with cation exchanger for determination of intermolecular crosslinks, pyridinoline and pentosidine, in hydrolysate. J. Liq. Chromatogr. 16: 1355, 1993.
18. Fujiwara M., Ishida Y., Nimura N., Toyama A., Kinoshita T. Postcolumn fluorometric detection system for liquid Chromatographic analysis of amino and imino acids using ophthalalehyde/N-acetyl-L-cysteine reagent. Anal. Biochem. 166: 72, 1987.
19. Tada K., Yamamuro T., Okumura H., Kasai R., Takahashi H. Restoration of axial and appendicular bone volumes by h-PTH(1-34) in parathyroidectomized and osteopenic rats. Bone 11: 163, 1990.
20. Villaneueva A.R. A bone stain for osteoid seams in fresh, umembeded mineralized bone. Stain Technol. 49: 1, 1974.
21. Parfitt A.M., Drenzner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., Recker R.R. Bone histomorphometry: Standardization of nomenclature, symbols, and units. J. Bone Miner. Res. 6: 595, 1987.
22. Katz I., Li M., Joffe I., Stein B., Jacobs T., Liang X.G., Ke H.Z., Jee W., Epstein S. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo. J. Bone Miner. Res. 1: 59, 1994.
23. Stein B., Takizawa M., Kaiz I., Joffe I., Berlin J., Fallon M., Epstein S. Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss. Endocrinology 129, 92, 1991.
24. 3 modifies cyclosporin-induced bone loss. Calcif. Tissue Int. 47: 152, 1990.
25. Schlosberg M., Movsowitz C., Epstein S., Ismail F., Fallon M.D., Thomas S. The effect of cyclosporin A administration and its withdrawal on bone mineral metabolism in the rat. Endocrinology 124: 2179, 1989.
26. 2 alleviates cyclosporin A-induced bone loss in the rat. J. Bone Miner. Res. 10: 1191, 1992.
27. Epstein S., Takizawa M., Stein B., Katz I.A., Joffe I.I., Romero D.F., Liang X.G., Li M., Ke H.Z., Jee W.S.S., Jacobs T.W., Berlin J. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat. J. Bone Miner. Res. 4: 557, 1994.
28. Bryer H.P., Isserow J.A., Armstrong E.C., Mann G.N., Rucinski B., Buchinsky F.J., Romero D.F., Epstein S. Azathioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. J. Bone Miner. Res. 1: 132, 1995.
29. Klein L., Lemel M.S., Wolfe M.S., Shaffer J. Cyclosporin A does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat. Calcif. Tissue Int. 55: 295, 1994.
30. Tordjman C., Lhumeau A., Pastoureau P., Meunier F., Serkiz B., Volland J.P., Bonnet J. Evaluation and comparison of urinary pyridinum cross links in two rat models of bone loss- ovariectomy and adjuvant polyarthritis- using a new automated HPLC. Bone Mineral. 26: 155, 1994.
31. Egger C.D., Muhlbauer R.C., Felix R., Delmas P.D., Marks S.C., Fleisch H. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat. J. Bone Miner. Res. 8: 1211, 1994.